Signaling events mediated by HDAC Class III

No Pathway Network information available for Signaling events mediated by HDAC Class III

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Signaling events mediated by HDAC Class III SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Tessadori-bicknell-van haaften neurodevelopmental syndrome 1EnrichmentH4C1, H4C35.12
2Tessadori-bicknell-van haaften neurodevelopmental syndrome 2EnrichmentH4C1, H4C115.12
3Tessadori-bicknell-van haaften neurodevelopmental syndrome 4EnrichmentH4C1, H4C94.64
4Tessadori-bicknell-van haaften neurodevelopmental syndrome 3EnrichmentH4C1, H4C54.64
5Rhabdomyosarcoma 2EnrichmentFOXO1, TP534.12
6Myeloma, multipleEnrichmentH1-4, HDAC4, TP533.29
7Diffuse large b-cell lymphomaEnrichmentFOXO1, TP532.90
8Colorectal cancerEnrichmentBAX, EP300, TP532.74
9Chromosome 2q37 deletion syndromeEnrichmentHDAC42.55
10Bone marrow failure syndrome 5EnrichmentTP532.55
11Papilloma of choroid plexusEnrichmentTP532.55
12Basal cell carcinoma 7EnrichmentTP532.55
13Anaplastic thyroid carcinomaEnrichmentTP532.55
14Rahman syndromeEnrichmentH1-42.55
15Congenital myopathy 17EnrichmentMYOD12.55
16Ductal carcinoma in situEnrichmentTP532.55
17Neurodevelopmental disorder with central hypotonia and dysmorphic faciesEnrichmentHDAC42.55
18Thyroid gland undifferentiated carcinomaEnrichmentTP532.55
19Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP532.55
20Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP532.55
21Choroid plexus cancerEnrichmentTP532.55
22Pleomorphic xanthoastrocytomaEnrichmentTP532.55
23Bladder cancerEnrichmentCDKN1A, TP532.53
24Complex neurodevelopmental disorderEnrichmentH4C3, H4C5, H4C92.30
25Adrenocortical carcinoma, hereditaryEnrichmentTP532.25
26Cervical cancerEnrichmentTP532.25
27Lymphoma, hodgkin, classicEnrichmentTP532.25
28Menke-hennekam syndrome 2EnrichmentEP3002.25
29Congenital fibrosarcomaEnrichmentTP532.25
30Li-fraumeni syndrome 1EnrichmentTP532.25
31SarcomaEnrichmentTP532.25
32Cervix carcinomaEnrichmentTP532.25
33Hodgkin's lymphomaEnrichmentTP532.25
34Pleomorphic rhabdomyosarcomaEnrichmentTP532.25
35Osteogenic sarcomaEnrichmentTP532.08
36Nasopharyngeal carcinomaEnrichmentTP532.08
37Cortical dysplasia, complex, with other brain malformations 5EnrichmentTUBB2A2.08
38Atypical teratoid rhabdoid tumorEnrichmentTP532.08
39Anaplastic astrocytomaEnrichmentTP532.08
40Squamous cell carcinomaEnrichmentTP532.08
41T-cell acute lymphoblastic leukemiaEnrichmentBAX2.08
42AdenocarcinomaEnrichmentTP532.08
43Bone osteosarcomaEnrichmentTP532.08
44Small cell cancer of the lungEnrichmentTP531.95
45Thyroid cancer, nonmedullary, 1EnrichmentTP531.95
46Lung sarcomatoid carcinomaEnrichmentTP531.95
47TubulinopathyEnrichmentTUBB2A1.95
48Embryonal rhabdomyosarcomaEnrichmentTP531.95
49Rubinstein-taybi syndrome 2EnrichmentEP3001.86
50LymphomaEnrichmentTP531.86
51Acute megakaryocytic leukemiaEnrichmentTP531.86
52Li-fraumeni syndromeEnrichmentTP531.78
53Myopathy, centronuclear, 1EnrichmentMYOD11.78
54Rubinstein-taybi syndrome 1EnrichmentEP3001.78
55Chromosome 16p13.3 deletion syndrome, proximalEnrichmentEP3001.78
56Adrenocortical carcinomaEnrichmentTP531.78
57Breast adenocarcinomaEnrichmentTP531.78
58Esophageal cancerEnrichmentTP531.71
59Multiple endocrine neoplasia, type iEnrichmentCDKN1A1.71
60Squamous cell carcinoma, head and neckEnrichmentTP531.71
61Essential thrombocythemiaEnrichmentTP531.71
62Gallbladder cancerEnrichmentTP531.71
63B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentTP531.71
64Glioma susceptibility 1EnrichmentTP531.65
65Lymphoma, non-hodgkin, familialEnrichmentTP531.65
66Orofacial cleft 1EnrichmentACSS21.60
67Charge syndromeEnrichmentEP3001.60
68Adult hepatocellular carcinomaEnrichmentTP531.60
69Primary hyperaldosteronismEnrichmentTP531.60
70Leukemia, chronic lymphocyticEnrichmentTP531.56
71Familial colorectal cancerEnrichmentTP531.56
72Myelodysplastic syndromeEnrichmentTP531.52
73Lip and oral cavity carcinomaEnrichmentTP531.48
74Lung cancer susceptibility 3EnrichmentTP531.41
75Polydactyly, postaxial, type a1EnrichmentEP3001.38
76Rare genetic intellectual disabilityEnrichmentEP3001.38
77RhabdomyosarcomaEnrichmentTP531.36
78GliosarcomaEnrichmentTP531.36
79Giant cell glioblastomaEnrichmentTP531.33
80HepatoblastomaEnrichmentTP531.24
81Hepatocellular carcinomaEnrichmentTP531.22
82Diamond-blackfan anemia 1EnrichmentTP531.20
83Pancreatic cancerEnrichmentTP531.17
84Auditory neuropathyEnrichmentH1-41.15
85Prostate cancerEnrichmentTP531.11
86Diamond-blackfan anemiaEnrichmentTP531.02
87Fetal akinesia deformation sequence 1EnrichmentMYOD11.01
88Leukemia, acute myeloidEnrichmentTP530.97
89Distal arthrogryposisEnrichmentMYOD10.95
90Gastric cancerEnrichmentTP530.94
91Hereditary breast carcinomaEnrichmentTP530.93
92Familial isolated dilated cardiomyopathyEnrichmentFHL20.86
93Hereditary breast ovarian cancer syndromeEnrichmentTP530.84
94Frontotemporal dementia and/or amyotrophic lateral sclerosis 7EnrichmentPPARGC1A0.82
95Breast cancerEnrichmentTP530.72
96Ovarian cancerEnrichmentTP530.61
97MicrocephalyEnrichmentEP3000.53
98Inherited cancer-predisposing syndromeEnrichmentTP530.51

Loading...
Loading...
Loading...